Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications

OMB 0910-0796

OMB 0910-0796

The Food and Drug Administration (FDA) is requesting approval of a new generic for collecting information through the use of qualitative methods for studies about tobacco products. FDA will employ qualitative research, including individual in-depth interviews (IDIs), small group discussions, and focus groups to explore knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.

The latest form for Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications expires 2021-07-31 and can be found here.

Latest Forms, Documents, and Supporting Material
Document
Name
Supplementary Document
Supplementary Document
Justification for No Material/Nonsubstantive Change
Supplementary Document
Supporting Statement B
Supporting Statement A
All Historical Document Collections
 Extension without change of a currently approved collection 2024-07-05
Approved without change
 No material or nonsubstantive change to a currently approved collection 2022-11-22
Approved without change
 Extension without change of a currently approved collection 2021-06-16
Approved without change
 No material or nonsubstantive change to a currently approved collection 2020-07-13
Approved without change
 No material or nonsubstantive change to a currently approved collection 2020-02-06
Approved with change
 Extension without change of a currently approved collection 2018-05-17
Approved with change
 New collection (Request for a new OMB Control Number) 2014-12-10
OMB Details

5-day turnaround Gen IC: Rapid Message Testing with Consumer Panel-Nicotine Dialogue Campaign Branding

Federal Enterprise Architecture: Health - Consumer Health and Safety

© 2024 OMB.report | Privacy Policy